Fund HoldingsTAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$289.04M
Total Bought
$1.42M
Total Sold
$45.35M
Net Transaction
-$43.94M
Filing Period:
Securities
SharesValue ($K)
Q4 2023
Q1 2024
Change
Q4 2023
Q1 2024
Weight (%)
Change
HilleVax, Inc.6,724,0006,724,0000107,921111,82138.69%+3,900
Equillium, Inc.1,824,9771,824,97701,3144,2161.46%+2,902
Day One Biopharmaceuticals, Inc.
COM
085,840+85,84001,4180.49%+1,418
Xilio Therapeutics, Inc.1,475,1211,475,12108111,5930.55%+782
Wave Life Sciences Ltd.(WVE)1,346,8921,346,89207,5708,3102.88%+741
Aerovate Therapeutics, Inc.13,58013,58003074020.14%+94
Turnstone Biologics Corp.895,824895,82402,2802,3470.81%+67
STANDARD BIOTOOLS INC.16,51516,515036450.02%+8
Rani Therapeutics Holdings, Inc.338,679338,67901,1241,0530.36%-71
Akili, Inc.738,819738,81903602140.07%-146
Denali Therapeutics Inc.(DNLI)4,214,5594,214,559086,94686,48329.92%-464
American Well Corp1,554,6691,554,66902,3161,2600.44%-1,056
Ovid Therapeutics Inc.7,531,9967,531,996024,25322,9737.95%-1,280
Shattuck Labs, Inc.2,090,8581,501,061-589,79714,90813,4194.64%-1,489
Phathom Pharmaceuticals, Inc.7,459,2863,153,217-4,306,06977,35333,48711.59%-43,866
Page 1 of 1